---
title: "LSBCF.US (LSBCF.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/LSBCF.US/news.md"
symbol: "LSBCF.US"
name: "LSBCF.US"
parent: "https://longbridge.com/zh-CN/quote/LSBCF.US.md"
datetime: "2026-03-17T06:57:11.899Z"
locales:
  - [en](https://longbridge.com/en/quote/LSBCF.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/LSBCF.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/LSBCF.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/LSBCF.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/LSBCF.US/news.md)


# LSBCF.US (LSBCF.US) — 相关新闻

### [07:00 ETLakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders](https://longbridge.com/zh-CN/news/275121304.md)
*2026-02-06T12:00:42.000Z*
> LakeShore Biopharma has received a notice from a Buyer Group regarding a going-private transaction at $0.90 per share. T

### [Lytix Biopharma Wins Shareholder Backing for NOK 30m Offering and Conversion to Public Company](https://longbridge.com/zh-CN/news/273730660.md)
*2026-01-26T17:03:41.000Z*
> Lytix Biopharma AS has received shareholder approval for a NOK 30 million offering and will convert to a public limited